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THE HYPOXIC TRANSCRIPTOME OF THE RETINA: 
IDENTIFICATION OF FACTORS WITH POTENTIAL 
NEUROPROTECTIVE ACTIVITY 
Markus Thiersch1*, Wolfgang Raffelsberger2, Enrico Frigg1, Marijana 
Samardzija1, Patricia Blank1, Olivier Poch2, and Christian Grimm1 
1. INTRODUCTION 
 
Most blinding diseases of the retina share a common feature – the loss of 
photoreceptor cells by apoptosis. Although degenerative diseases like age-related macular 
degeneration (AMD) and Retinitis Pigmentosa (RP) are among the main causes for 
severe visual impairment and blindness, no effective therapeutical treatments are 
available to prevent loss of vision in human patients. Protection of retinal cells against 
cell death is a promising strategy to develop therapies aiming at the rescue of retinal 
function. For the successful design of neuroprotective strategies, it is essential to 
understand the molecular events leading to the degeneration of retinal cells. To study 
signaling pathways and molecular mechanisms during the degenerative processes, several 
mouse models of inherited retinal degeneration are used (Fauser et al. 2002). These 
models are complemented by models of induced photoreceptor apoptosis like the model 
of light-induced degeneration (Wenzel et al. 2005). The advantage of the induced models 
is the synchronized apoptotic response of many photoreceptor cells to the death stimulus. 
This might raise the activation of regulatory factors above detection threshold allowing 
their detailed investigation. 
Recently, we showed that hypoxic preconditioning protects photoreceptor cells 
against light-induced cell death by preserving retinal function and morphology (Grimm et 
al. 2002). Similarly, hypoxic pretreatment can also protect other tissues like heart or brain 
against various toxic insults (Gidday et al. 1994; Emerson et al. 1999; Cai et al. 2003; 
Dong et al. 2003) suggesting that hypoxic preconditioning might induce a general 
protective response. Such a response might involve hypoxia-inducible-factor 1a (HIF-1a) 
which is stabilized in the retina after hypoxic exposure (Grimm et al. 2002). As a 
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transcription factor, HIF-1a (together with HIF-2a) is a key element of the hypoxic 
response regulating expression of many target genes. Such genes are involved in different 
physiological functions like angiogenesis, general metabolism and apoptosis. One target 
gene of HIF-1a and/or HIF-2a has been identified in erythropoietin (Epo). Epo was 
shown to prevent death of precursor cells of erythrocytes in bone marrow and was thus 
recognized as a potent anti-apoptotic factor (Koury et al. 2002). Since expression of Epo 
is strongly induced after hypoxic preconditioning in the retina and Epo receptor 
expression was localized mainly to photoreceptor and ganglion cells (Bocker-Meffert et 
al. 2002; Grimm et al. 2002; Grimm et al. 2004), Epo was considered to be a factor 
protecting the retina against degeneration. Supporting this conclusion, application of 
recombinant Epo protected photoreceptor cells against light-induced degeneration. 
However, protection was not as complete as after hypoxic preconditioning suggesting 
that exposure to reduced oxygen levels may differentially regulate expression of 
additional genes involved in the protection of photoreceptor cells (Grimm et al. 2002; 
Grimm et al. 2004). 
The goal of the present study was to analyze the retinal response to hypoxia and to 
identify differentially regulated genes that might be involved in retinal neuroprotection. 
 
 
2. MATERIAL AND METHODS 
2.1. Hypoxic preconditioning and Affymetrix microarrays 
Animals were treated in accordance with the regulations of the Veterinary Authority 
of Zurich and with the statement of ‘The Association for Research in Vision and 
Ophthalmology’ for the use of animals in research. BALB/c mice (Harlan, The 
Netherlands) were exposed to 6% oxygen for 6 h. Retinas were isolated at 0 h, 2 h, 4 h or 
16 h after the period of hypoxic preconditioning. Normoxic controls were treated in 
parallel and collected at the same time points. For each condition three retinas of three 
different mice were pooled. Total RNA was prepared, processed according to standard 
procedures and hybridized to Affymetrix GeneChip® Mouse Genome 430 2.0 
microarrays. The experiment was conducted three times independently resulting in three 
microarray replicates per condition and a total number of 9 retinas per condition. 
2.2. Quality control and Affymetrix chip analyzes 
To analyze the quality of the results after gene chip hybridization the online tool 
RACE (Remote Analysis Computation for gene Expression data) of the University of 
Lausanne was used. 
To analyze gene expression profiles and to identify differentially regulated genes, we 
used Genespring 7.0 (Agilent Technologies) software based on the Mas5.0 algorithm. In 
brief, hypoxic samples (H, hypoxic) were compared to their corresponding normoxic 
controls (N, normoxic) resulting in 4 different analyzes: N0 vs. H0, N2 vs. H2, N4 vs. H4 
and N16 vs. H16. In the first step, genes were tested for their presence or absence in the 
samples. Genes were considered to be expressed and allowed to pass the filter only when 
all 3 replicates of a particular condition (normoxic, hypoxic) got a present call. Genes that 
passed the first filter were then analyzed and filtered according to their fold change (at 
least factor 2) and to their p-value (≤ 0.05). Additionally, a statistical correction 
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according to Benjamini/Hochberg (Benjamini and Hochberg 1995) was applied. To sort 
differentially regulated genes according to their biological function the online tool Onto-
Express from Intelligent Systems and Bioinformatics Laboratory (Draghici et al. 2003a; 
Draghici et al. 2003b; Draghici et al. 2003c) was used (http://vortex.cs.wayne.edu/projects.htm). 
2.3. Real-time PCR 
Gene regulation was confirmed by real-time PCR on cDNA prepared from total 
retinal RNA, using a LightCycler 480 instrument (Roche Diagnostics AG, Rotkreuz, 
Switzerland) and LightCycler 480 SYBR Green I Master Mix (Roche Diagnostics AG). 
Primers were designed using the Universal ProbeLibrary Assay Design Centre (Roche 
Diagnostics AG) https://www.roche-applied-science.com. Relative expression was 
calculated according to the expression of b-actin using the LightCycler software package. 
2.4. Light exposure and quantification of cell death 
p21–/– mice on a mixed Bl/6;129S2 background were purchased from Jackson 
Laboratory (Bar Harbor, USA). Mice homozygous for the light sensitive Rpe65450Leu 
variant (Wenzel et al. 2001; Samardzija et al. 2006) were used to establish the breeding 
colony. After hypoxic preconditioning (see 2.1.) mice were reoxygenated in darkness 
(dark adaptation) for 4 hours prior to illumination. 45 minutes prior to illumination, 
pupils were dilated in dim red light using 1% Cyclogyl (Alcon, Cham, Switzerland) and 
5% Phenylephrine (Ciba Vision, Niederwangen, Switzerland). Mice were exposed to 
13’000 lux of white fluorescent light for 2 hours.  
36 hours after light exposure apoptotic cell death was quantified in isolated retinas 
using a sandwich ELISA system (Cell Death Detection ElisaPlus, Roche Diagnostics, 
Basel, Switzerland, used according to the manufacturer's recommendation) to determine 
the relative amount of free nucleosomes in the cytosolic fraction of isolated retinas.  
2.5. Morphology 
Eyes were removed and fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 
7.3 at 4°C overnight. For each eye, the superior central and the inferior central retina 
adjacent to the optic nerve were trimmed and embedded in Epon 812. Sections (0.5 µm) 
were prepared from the inferior central retina, stained with toluidine blue and analyzed 
using an Axioplan microscope (Zeiss, Oberkochen, Germany). 
 
 
3. RESULTS 
3.1. Statistical Analyzes 
Hypoxic preconditioning was shown to completely protect photoreceptor cells 
against light–induced cell death when the light stimulus was given after a reoxygenation 
period of 4 h (Grimm et al. 2002). In contrast, mice exposed to light at 16 h after hypoxic 
preconditioning were not protected suggesting that the protective effect of hypoxia is 
transient and short-lived. Based on these findings we decided to analyze the retinal 
transcriptome at 4 different time points after hypoxic preconditioning. The first three time 
points were within the frame of full neuroprotection (0 h, +2 h, +4 h) whereas the last
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Table 1. Total number of genes differentially regulated at 0 h, 2 h, 4 h and 16 h after 
hypoxia. 
 
Condition Altered Genes with Benjamini/Hochberg False positive 
Altered Genes without 
Benjamini/Hochberg False positive 
H0 vs. N0 83 4 772 96 
H2 vs. N2 7 - 189 24 
H4 vs. N4 0 - 74 9 
H16 vs. N16 0 - 24 3 
Shown are the numbers of genes passing the stringent Benjamini/Hochberg correction in comparison to a 
normal t-test. The columns ‘false positive’ show the expected number of genes which have passed the 
respective test but which are nevertheless not differentially regulated. H0, H2, H4, H16: retinas at 0h, 2h, 4h 
and 16h, respectively, after hypoxic preconditioning. N0, N2, N4, N16: control normoxic retinas. 
 
time point was taken after neuroprotection has ceased (+16 h). Quality controls were used 
to confirm the successful performance of the experiment. Analyzes, which compare the 
global similarity of all gene chips indicated that hypoxic replicates were very similar 
within their groups and highly different to their normoxic controls (data not shown). 
Genespring 7.0 software was used to detect genes that were differentially regulated 
by hypoxic exposure. In this first statistical analysis without mathematical correction 772 
genes appeared to be differentially regulated immediately after hypoxia. This number 
decreased during reoxygenation to 189 genes after 2 h, 74 genes after 4 h and 24 genes 16 
h after hypoxia (Table 1). After application of the highly stringent statistical method of 
Benjamini/Hochberg (Benjamini and Hochberg 1995), we identified a total of 83 genes 
as significantly regulated immediately after hypoxic preconditioning. Already at 2 h after 
hypoxia, only 7 genes remained to have significantly different expression levels and at 4 
h and 16 h after hypoxia the retinal transcriptome of preconditioned mice was 
indistinguishable from normoxic controls (Table 1). Both statistical methods indicated 
that differential regulation of gene expression is strongest immediately after hypoxia. 
During reoxygenation, the retinal transcriptome quickly returned to the normoxic gene 
expression pattern suggesting a short-lived molecular effect of hypoxic preconditioning.  
3.2. Biological classification 
It is eminent to sort differentially regulated genes according to their biological 
relevance. Using the statistical online tool “Onto express” we classified the identified 
genes with respect to their various biological functions like apoptosis, transport, cell 
cycle and others (Fig. 1). The highest number of regulated genes was sorted into the 
group of transport-related genes followed by apoptosis-related processes. This may be of 
high relevance since hypoxic preconditioning induces a neuroprotective response in the 
retina, which most likely involves a number of genes related to the control of apoptotic 
events. Having in mind, that genes can be present in more than one biological group, the 
number of sorted genes does not reflect the real number of genes identified as 
differentially regulated. Individual genes of the group of ‘anti-apoptotic’ or the group of 
‘induction of apoptosis’ were also found in the group ‘apoptosis’. Table 2 summarizes 
differentially regulated genes that are considered anti-apoptotic. Note that some of these 
genes are repressed by the hypoxic pretreatment. Table 3 shows the most prominently 
regulated pro-apoptotic genes. In total, 13 genes with a known anti-apoptotic function 
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Figure 1. Classification of differentially expressed genes according to their biological function. Genes regulated 
immediately after hypoxia (0 h) without statistical correction were classified using Onto-Express. Only most 
prominent and statistically significant (p ≤ 0.05) groups are shown. Numbers of genes in each group are given 
in brackets. 
 
 
Table 2. Differentially regulated genes with anti-apoptotic functions. 
 
Gene FC 0 h FC 2 h FC 4 h FC 16 h 
p21 34.4 - - - 
Bcl2-like 10 6.3 - - - 
Snai2 - 3.1 - - 
Vegfa 2.6 - - - 
Bhlhb4 2.3 - - - 
Bfar 2.2 - - - 
Camk1d - 2.2 2.0 - 
Birc6 - 2.1 - - 
C/EBP 2.0 2.3 - - 
     
p21-activated kinase 7 0.46 - - - 
Apoptosis inhibitor 5 0.34 - - - 
Glutaminyl-tRNA-Synthetase 0.32 - - - 
Birc4 0.22 - - - 
Shown are the gene-chip deduced fold-changes (FC) at 0h, 2h, 4h and 16h after hypoxic preconditioning. p21 
is the most prominently up-regulated gene within this group. -; not detected 
 
 
Table 3. Differentially regulated genes with pro-apoptotic functions. 
 
Gene FC 0 h FC 2 h FC 4 h FC 16 h 
Pmaip1 12.9 - - - 
Sh3glb1 (endophilin) 5 4.7 - - 
Bnip3 2.3 - - - 
BCL2-like 11 2.2 - - - 
Foxo3a 2.1 - - - 
Shown are the gene-chip deduced fold-changes (FC) at 0h, 2h, 4h and 16h after hypoxic 
preconditioning. . -; not detected 
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were differentially regulated by hypoxia. Nine genes were induced whereas 4 genes were 
repressed (Table 2). Test of VEGF, p21 and Bcl2l10 gene expression by real-time PCR 
confirmed the chip data and their up-regulation in response to the hypoxic pretreatment 
(Fig. 2). In addition to the anti-apoptotic genes, expression of 5 genes expected to be pro-
apoptotic was induced during hypoxia (Table 3).  
Having both, pro- and anti-apoptotic genes regulated by hypoxia suggests that the 
preconditioning protocol induces a complex response priming the tissue to resist a toxic 
insult but also preparing the cells to induce apoptotic cell death if needed. We 
hypothesize that reducing the number of cells may be required in case of prolonged 
hypoxic exposure to ensure that at least some cells can be supplied with sufficient oxygen 
to function. 
 
Vegf p21 Bcl2l10
0
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2
3
Normoxia
Hypoxia
10
20
30
40
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**
***
 
 
Figure 2. Expression of apoptosis-related genes immediately after hypoxic preconditioning relative to normoxic 
controls as determined by real-time PCR. Expression of Vegf, p21 and Bcl2l10 (as indicated) was determined in 
three normoxic and three hypoxic retinas. Amplifications were done in duplicates. Normoxic samples were set 
to 1 and hypoxic samples represent the relative fold change due to hypoxia. 
 
3.3. The neuroprotective impact of p21 
One of the most prominently induced genes with reported anti-apoptotic properties 
was p21, a cyclin-dependent kinase inhibitor. To analyze its role in neuroprotection by 
hypoxic preconditioning, p21 knockout mice were exposed to hypoxia, reoxygenated for 
4 hours and exposed to 2 hours of 13,000 lux of white light. As controls, p21–/– mice were 
kept in normoxic conditions before light exposure. Light-induced photoreceptor apoptosis 
was analyzed 36 hours after exposure by light microscopy (Fig. 3A) and by the semi-
quantitative determination of free nucleosomes (Fig. 3B). In contrast to normoxic control 
mice, hypoxic preconditioned p21 knockout animals did not produce a significant amount 
of free nucleosomes after light-exposure suggesting that lack of p21 did not interfere with 
the neuroprotection by hypoxic preconditioning. These findings were confirmed by the 
morphological analysis of retinal tissue after light exposure (Fig. 3A). In contrast to 
normoxic controls where light exposure induced the formation of pyknotic nuclei and a 
severe disruption of rod inner and outer segments, retinal morphology of preconditioned 
knockout mice was completely protected. 
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Figure 3. Analysis of the role of p21 in retinal neuroprotection by hypoxic preconditioning. p21–/– mice were 
either kept in normoxia or were preconditioned with 6% O2 for 6 hours before light exposure. A) Retinal 
morphology was analyzed 36 hours after exposure. Normoxic mice (left panel) showed strong signs of 
degeneration with many pyknotic photoreceptor nuclei and severe destruction of inner and outer segments. 
Retinas of hypoxic preconditioned mice (right panel) were completely protected against light-induced 
degeneration. B) Cell death detection (CDD) assay to analyze the amount of free nucleosomes in the 
cytoplasmic fraction 36 h after light exposure. Normoxic mice showed a high content of free nucleosomes 
whereas hypoxic preconditioned mice showed no detectable release of nucleosomes. Shown are data points of 
two individual mice (dots) with the respective average (line). ROS: rod outer segments; RIS: rod inner 
segments; ONL: outer nuclear layer. 
 
 
4. DISCUSSION 
 
Photoreceptor cells are among the cells with the highest need for oxygen. Highest 
oxygen concentrations are measured at the level of the outer segments which are closest 
to the choroidal blood vessels. With increasing distance from the RPE and the choroidea, 
oxygen concentrations drop rapidly and photoreceptor cells can experience borderline 
hypoxic conditions at night, the time of highest energy consumption (Yu and Cringle 
2005). To react and/or adapt to such conditions, the retina needs a system that can sense 
oxygen levels and induce appropriate endogenous mechanisms in response to varying 
conditions. In a normal physiological situation, such a response may include an 
adaptation of the metabolism reducing or increasing the consumption of energy. In 
harsher conditions, the retina may prepare the cells to survive by the induction of an 
endogenous neuroprotective response. If unfavorable conditions persist, the sacrifice of 
some individual cells may be required in order to safe the function of the retinal tissue as 
a whole. Understanding the retinal response to hypoxia may lead to the identification of 
potent endogenous neuroprotective mechanisms. Artificial and controlled stimulation of 
such mechanisms may be beneficial for human patients suffering from loss of vision due 
to retinal degeneration. Furthermore, hypoxia is one of the driving forces for 
neovascularization, a major complication of many retinal diseases including diabetic 
retinopathy and AMD (Zhang and Ma 2007). Identification of the molecular mechanisms 
controlling the hypoxia-related production of angiogenic factors like VEGF may lead to 
the development of new and efficient treatments for these diseases. 
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Recently we showed that a transient period of strong hypoxia induces a molecular 
response in the retina which protects photoreceptors from the otherwise deleterious effect 
of light exposure (Grimm et al. 2002). A central regulator of this response might be the 
transcription factor HIF-1a which is stabilized and therefore activated in hypoxic 
conditions in several tissues including the retina (Grimm et al. 2002; Maxwell 2003; 
Sharp and Bernaudin 2004). However, since HIF-1a and other transcription factors 
modulate the expression of a large amount of genes (Ke and Costa 2006), the molecular 
mechanisms involved in the tissue response to hypoxia are still poorly understood and the 
molecular basis for hypoxia-induced neuroprotection remains unclear. Our study was 
therefore designed to increase our knowledge of hypoxia-dependent gene regulation and 
neuroprotection by analyzing the retinal transcriptome after hypoxic preconditioning. 
The highest number of differentially regulated genes was found immediately after 
hypoxia. At this time, HIF-1a is present at high levels suggesting that HIF-1a may indeed 
be one of the major factors controlling the hypoxic response in the retina. This is further 
supported by the rapid decline of HIF-1a levels (Grimm et al. 2002) and of differentially 
expressed genes during reoxygenation. 
The most prominent functional group affected by hypoxia was “transport” which 
includes genes of general metabolic activity like Slc37a4 (glucose-6phosphate 
transporter) or FABP4 (fatty acid binding protein 4). This may reflect an adaptational 
response of the retina, which may normally occur to a rather mild change in oxygen 
levels. Despite the strong neuroprotective capacity of hypoxic preconditioning, we also 
detected a number of differentially regulated genes that are pro-apoptotic and may 
therefore promote cell death. As discussed above, these factors may be produced to 
reduce the number of oxygen-consuming cells if low levels of oxygen persist. This might 
secure sufficient oxygen supply and therefore energy for a smaller cell population which 
may thus survive and function even in unfavorable conditions. Although this may reduce 
the general sensitivity of the retina, it may nevertheless rescue some (reduced) function. 
It might be interesting to analyze whether less severe hypoxic conditions would increase 
the differential regulation of genes involved in general metabolism and decrease the 
number of pro-apoptotic genes. 
Our focus, however, is the elucidation of the neuroprotective mechanisms in 
response to a harsh but transient hypoxic period. Therefore, we concentrated during our 
initial analysis on genes which might be involved in an anti-apoptotic response of the 
retina. Because p21 was one of the most prominently induced genes with known anti-
apoptotic functions (Zaman et al. 1999; Mahyar-Roemer and Roemer 2001), we focused 
on its potential role in neuroprotection after hypoxic preconditioning. We hypothesized 
that lack of p21 would reduce the neuroprotective effect if the gene was indeed involved 
in the protective response. However, mice with a functional knockout of p21 were highly 
protected against a toxic light insult when preconditioned with hypoxia. This suggests 
that this Cyclin dependent kinase inhibitor is at least not a major contributor to the 
neuroprotective response induced by hypoxic preconditioning. 
We will continue the analysis of individual genes identified in our screen. Future 
studies will focus on genes like Bcl2l10 or C/EBP which were up-regulated during 
hypoxia and which are known to be anti-apoptotic (Song et al. 1999; Naumann et al. 
2001; Buck and Chojkier 2003). Additionally, strongly up-regulated genes (not shown) 
like Paraoxonase 1, which is involved in oxidative stress response and lipid oxidation 
(Aviram et al. 1998) or Adrenomedullin, which was reported to be neuroprotective in 
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ischemia models (Miyashita et al. 2006) will be studied for their relevance to retinal 
neuroprotection after hypoxic preconditioning. 
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